Skip to content

Insulet PODD Total debt

Total debt at other companies

Eli Lilly logo
Eli LillyLLY
Medtronic logo
MedtronicMDT
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Abbott logo
AbbottABT
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's total debt?
Insulet (PODD) reported total debt of $969.7M in Q1 2026.
How has Insulet's total debt changed year-over-year?
Insulet's total debt decreased by 45.5% year-over-year, from $1.78B to $969.7M.
What is the long-term trend for Insulet's total debt?
Over 5 years (2020 to 2025), Insulet's total debt has grown at a -1.1% compound annual growth rate (CAGR), from $1.08B to $1.02B.
What does total debt mean?
The total amount of money the company owes to lenders and lessors.
How do you interpret total debt?
An increase suggests higher financial leverage and potential interest expense burden, while a decrease indicates deleveraging or improved debt repayment capacity. High levels relative to equity or cash flow may signal increased financial risk, particularly in rising interest rate environments.
How does total debt compare across companies?
Comparable to total debt figures reported by other medical device and healthcare technology companies, typically evaluated against EBITDA or total equity to assess solvency.